Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06172127Phase 2Active Not Recruiting
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
HER2-positive Breast Cancer
PrincipalinvestigatorStart date: 2024-07-22

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Antonio Llombart-Cussac, MD

Arnau de Vilanova Hospital, Valencia (Spain)

Related
3 trials

Shared therapeutic areas:

HER2-positive Breast CancerHER2-positive unresectable locally recurrent or metastatic breast cancer (MBC).

Worked with same sponsors:

Hoffmann-La RocheMedSIR
Collaborated on 1 trial
Similarity Score24%

Javier Cortés, MD, PhD

Institute of Breast Cancer, Quirón Group, Barcelona (Spain)

Related
2 trials

Shared therapeutic areas:

HER2-positive Breast CancerHER2-positive unresectable locally recurrent or metastatic breast cancer (MBC).

Worked with same sponsors:

Hoffmann-La RocheMedSIR
Collaborated on 1 trial
Similarity Score24%

Jonathan McConathy, MD, PhD

University of Alabama at Birmingham

Related
6 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Kamran Ahmed, MD

Moffitt Cancer Center

Related
4 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Shanu Modi, MD

Memorial Sloan Kettering Cancer Center

Related
6 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Qamar Khan, MD

University of Kansas Medical Center

Related
4 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Heath Badger

Breast Cancer Trials, Australia and New Zealand

Related
3 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Kun Wang, MD

Guangdong Provincial People's Hospital

Related
6 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

François-Clément Bidard

Institut Curie

Related
4 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Jonas Bergh, MD, PhD

Karolinska Institutet

Related
2 trials

Shared therapeutic areas:

HER2-positive Breast Cancer
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06172127Phase 2PrincipalInvestigator

PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer

HER2-positive Breast Cancer
Active Not Recruiting

All 1 trials loaded